3billion
Latest round
- Series C
Last raised
- Dec 2020
Total raised
- $18M
Investors
- 13
About 3billion
3billion was founded in 2016 in Seoul, South Korea, specializing in genetic testing for rare diseases.3billion specializes in genetic testing for rare diseases, offering products like 3B-GENOME, 3B-EXOME, 3B-VARIANT, and 3B-INTERPRETER that enable comprehensive genetic analyses via whole genome and exome sequencing. These products utilize buccal swabs for sample collection, thereby simplifying the diagnostic process for healthcare providers.40. The company generates revenue through B2B transactions with healthcare providers and institutions, often through one-time orders or contractual agreements for genetic tests.2 million shares at KRW 4,500 each, to enhance its research capabilities and expand its market reach. The company aims to introduce new products designed to improve the accuracy and efficiency of genetic testing. Additionally, it is targeting expansion into new geographic markets, including further penetration into Europe and Asia, aiming for significant market presence by 2025.
Who invested in 3billion
13 investors across 3 rounds
See all investors in 3billion
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about 3billion
Who invested in 3billion?
3billion has 13 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has 3billion raised?
3billion has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did 3billion last raise money?
3billion's most recent round on record is a Series C, in Dec 2020.
What does 3billion do?
3billion was founded in 2016 in Seoul, South Korea, specializing in genetic testing for rare diseases.
Where is 3billion headquartered?
3billion is headquartered in Seoul, South Korea.
Which VCs invest in companies like 3billion?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at 3billion's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like 3billion? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.